Vericel reports Q4 total revenue of USD 276 million, up 23 percent

Reuters
Jan 13
Vericel reports Q4 total revenue of USD 276 million, up 23 percent

Vericel Corporation reported preliminary, unaudited financial results for the full year ended December 31, 2025. Total net revenue is expected to be USD 276 million, with MACI net revenue of USD 239.5 million and Burn Care net revenue of USD 36.5 million. The company expects a gross margin of 74 percent and an adjusted EBITDA margin of 26 percent for the year. GAAP net income profitability is anticipated for the second consecutive year. These results remain subject to change pending completion of internal review and audit procedures.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vericel Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9624213) on January 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10